Jordana B Cohen1, Kevin C Eddinger2, Jayme E Locke3, Kimberly A Forde4,5, Peter P Reese6,4, Deirdre L Sawinski6. 1. Renal, Electrolyte, and Hypertension Division, jco@mail.med.upenn.edu. 2. Department of Surgery, and. 3. Department of Surgery, University of Alabama-Birmingham, Birmingham, Alabama; and. 4. Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. 5. Division of Gastroenterology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. 6. Renal, Electrolyte, and Hypertension Division.
Abstract
BACKGROUND AND OBJECTIVES: Use of diabetic donor kidneys has been a necessary response to the donor organ shortage. Recipients of diabetic donor kidneys have higher mortality risk compared with recipients of nondiabetic donor kidneys. However, the survival benefit of transplantation with diabetic donor kidneys over remaining on the waitlist has not been previously evaluated. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We performed an observational cohort study of 437,619 kidney transplant candidates from the Organ Procurement and Transplantation Network database, including 8101 recipients of diabetic donor kidneys and 126,560 recipients of nondiabetic donor kidneys. We used time-varying Cox proportional hazards modeling to assess the mortality risk of accepting a diabetic donor kidney compared with remaining on the waitlist or receiving a nondiabetic donor kidney. RESULTS: Among transplant recipients, median follow-up was 8.9 years and mortality rate was 35 deaths per 1000 person-years. Recipients of diabetic donor kidneys had 9% lower mortality compared with remaining on the waitlist or transplantation with a nondiabetic donor kidney (adjusted hazard ratio, 0.91; 95% confidence interval, 0.84 to 0.98). Although recipients of nondiabetic donor kidneys with a Kidney Donor Profile Index score >85% had lower mortality risk (adjusted hazard ratio, 0.86; 95% confidence interval, 0.81 to 0.91), recipients of diabetic donor kidneys with an index score >85% did not show any difference (adjusted hazard ratio, 1.09; 95% confidence interval, 0.97 to 1.22). Patients aged <40 years attained no survival benefit from transplantation with diabetic donor kidneys; diabetic patients at centers with long waitlist times attained the greatest survival benefit. CONCLUSIONS: Diabetic donor kidneys appear associated with higher mortality risk compared with nondiabetic donor kidneys, but offer greater survival benefit compared with remaining on the waitlist for many candidates. Patients with high risk of mortality on the waitlist at centers with long wait times appear to benefit most from transplantation with diabetic donor kidneys.
BACKGROUND AND OBJECTIVES: Use of diabetic donor kidneys has been a necessary response to the donor organ shortage. Recipients of diabetic donor kidneys have higher mortality risk compared with recipients of nondiabetic donor kidneys. However, the survival benefit of transplantation with diabetic donor kidneys over remaining on the waitlist has not been previously evaluated. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We performed an observational cohort study of 437,619 kidney transplant candidates from the Organ Procurement and Transplantation Network database, including 8101 recipients of diabetic donor kidneys and 126,560 recipients of nondiabetic donor kidneys. We used time-varying Cox proportional hazards modeling to assess the mortality risk of accepting a diabeticdonor kidney compared with remaining on the waitlist or receiving a nondiabetic donor kidney. RESULTS: Among transplant recipients, median follow-up was 8.9 years and mortality rate was 35 deaths per 1000 person-years. Recipients of diabetic donor kidneys had 9% lower mortality compared with remaining on the waitlist or transplantation with a nondiabetic donor kidney (adjusted hazard ratio, 0.91; 95% confidence interval, 0.84 to 0.98). Although recipients of nondiabetic donor kidneys with a Kidney Donor Profile Index score >85% had lower mortality risk (adjusted hazard ratio, 0.86; 95% confidence interval, 0.81 to 0.91), recipients of diabetic donor kidneys with an index score >85% did not show any difference (adjusted hazard ratio, 1.09; 95% confidence interval, 0.97 to 1.22). Patients aged <40 years attained no survival benefit from transplantation with diabetic donor kidneys; diabeticpatients at centers with long waitlist times attained the greatest survival benefit. CONCLUSIONS:Diabetic donor kidneys appear associated with higher mortality risk compared with nondiabetic donor kidneys, but offer greater survival benefit compared with remaining on the waitlist for many candidates. Patients with high risk of mortality on the waitlist at centers with long wait times appear to benefit most from transplantation with diabetic donor kidneys.
Authors: I Gandolfini; C Buzio; P Zanelli; A Palmisano; E Cremaschi; A Vaglio; G Piotti; L Melfa; G La Manna; G Feliciangeli; M Cappuccilli; M P Scolari; I Capelli; L Panicali; O Baraldi; S Stefoni; A Buscaroli; L Ridolfi; A D'Errico; G Cappelli; D Bonucchi; E Rubbiani; A Albertazzi; A Mehrotra; P Cravedi; U Maggiore Journal: Am J Transplant Date: 2014-08-25 Impact factor: 8.086
Authors: John J Friedewald; Ciara J Samana; Bertram L Kasiske; Ajay K Israni; Darren Stewart; Wida Cherikh; Richard N Formica Journal: Surg Clin North Am Date: 2013-12 Impact factor: 2.741
Authors: Akinlolu O Ojo; Julie A Hanson; Herwig-Ulf Meier-Kriesche; Chike N Okechukwu; Robert A Wolfe; Alan B Leichtman; Lawrence Y Agodoa; Bruce Kaplan; Friedrich K Port Journal: J Am Soc Nephrol Date: 2001-03 Impact factor: 10.121
Authors: Ajay K Israni; Nicholas Salkowski; Sally Gustafson; Jon J Snyder; John J Friedewald; Richard N Formica; Xinyue Wang; Eugene Shteyn; Wida Cherikh; Darren Stewart; Ciara J Samana; Adrine Chung; Allyson Hart; Bertram L Kasiske Journal: J Am Soc Nephrol Date: 2014-05-15 Impact factor: 10.121
Authors: Jordana B Cohen; Roy D Bloom; Peter P Reese; Paige M Porrett; Kimberly A Forde; Deirdre L Sawinski Journal: Kidney Int Date: 2015-10-21 Impact factor: 10.612
Authors: Hye Won Seo; Sua Lee; Hwa Young Lee; Sun Cheol Park; Byung Ha Chung; Chul Woo Yang; Tae Hyun Ban Journal: World J Clin Cases Date: 2020-02-06 Impact factor: 1.337
Authors: Jordana B Cohen; Vishnu Potluri; Paige M Porrett; Ruohui Chen; Marielle Roselli; Justine Shults; Deirdre L Sawinski; Peter P Reese Journal: Am J Transplant Date: 2019-03-02 Impact factor: 8.086
Authors: Deirdre Sawinski; Kimberly A Forde; Vincent Lo Re; David S Goldberg; Jordana B Cohen; Jayme E Locke; Roy D Bloom; Colleen Brensinger; Joe Weldon; Justine Shults; Peter P Reese Journal: Am J Kidney Dis Date: 2019-01-29 Impact factor: 8.860
Authors: Rhiannon D Reed; Brittany A Shelton; Margaux N Mustian; Paul A MacLennan; Deirdre Sawinski; Jayme E Locke Journal: Transplantation Date: 2020-02 Impact factor: 5.385
Authors: S Ali Husain; Kristen L King; Stephen Pastan; Rachel E Patzer; David J Cohen; Jai Radhakrishnan; Sumit Mohan Journal: JAMA Netw Open Date: 2019-08-02